[Drug interactions through influencing plasma-protein binding]
- PMID: 376478
[Drug interactions through influencing plasma-protein binding]
Similar articles
-
Drug therapy. Binding of drugs to serum albumin (second of two parts).N Engl J Med. 1976 Mar 4;294(10):526-31. doi: 10.1056/NEJM197603042941005. N Engl J Med. 1976. PMID: 765821 Review. No abstract available.
-
Drug binding to plasma proteins.N Z Med J. 1985 Apr 10;98(776):245-8. N Z Med J. 1985. PMID: 3857503 No abstract available.
-
[Change in the pharmacokinetics of drug substances in kidney diseases].Klin Med (Mosk). 1980 May;58(5):13-6. Klin Med (Mosk). 1980. PMID: 6991802 Review. Russian. No abstract available.
-
[Pharmacokinetics as a basic pharmacological problem].Acta Diabetol Lat. 1969 Sep;6 Suppl 1:59-73. Acta Diabetol Lat. 1969. PMID: 4906026 Review. Multiple languages. No abstract available.
-
Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.Ther Drug Monit. 1980;2(4):331-44. Ther Drug Monit. 1980. PMID: 7013166 Review.
Cited by
-
The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.Klin Wochenschr. 1983 Sep 1;61(17):851-8. doi: 10.1007/BF01537460. Klin Wochenschr. 1983. PMID: 6632727 Clinical Trial.
-
Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.Cancer Chemother Pharmacol. 1989;23(2):76-80. doi: 10.1007/BF00273521. Cancer Chemother Pharmacol. 1989. PMID: 2910515